Success Stories: An Indian Research Associate in the Field of Pharmacology Secures O1-A Approval in Just 7 Days with Our Vigilant Assistance in His Petition Preparation & Submission
Client’s Testimonial:
“Thank you so much for sharing this news with me. I am thankful to the whole team. I would love to give a 5-star rating to Chen Immigration Team, again thank you so much for your help!”
On January 10th, 2022, we received another O1-A (Individuals with Extraordinary Ability or Achievement) approval for a Research Associate 3 in the Field of Pharmacology (Approval Notice).
General Field: Pharmacology
Position at the Time of Case Filing: Research Associate 3
Country of Origin: India
State of Residence at the Time of Filing: Texas
Approval Notice Date: January 10th, 2022
Processing Time: 7 days (Premium Processing Requested)
Case Summary:
A Texas-based research associate from India in the field of pharmacology hired North America Immigration Law Group to help him build a substantial O1A (Individual with Extraordinary Ability or Achievement) case on his behalf to demonstrate how he has spent several years researching the neurodegeneration and brain tumors, addressing our nation’s vital issues in understanding the underlying mechanisms that cause neurodegenerative disease development.
Since we have a successful record of approved I-129 cases, we were certain that our client’s credentials, a consistent impressive record of success, and influence in these areas of study would achieve the O1A visa. We established the same by summarizing a documented record of his authorship in the field of pharmacology which resulted in 10 peer-reviewed scientific articles and 1 book, gathering a total of 451 citations by many other researchers in the field.
In addition, his peer-review experience, where he has conducted 17 reviews to date, shows that he is highly valued as an expert at the top of his field of pharmacology.
To corroborate our client's petition packet further, we added four recommendation letters signed by his fellow experts. One of them stated the following:
“The quality of his work, as evidenced by the foregoing discussion, is in fact of a level that distinguishes him as a leading expert in the field today. For this reason, I highly recommend that [client] is given every opportunity available to work in the United States for the advancement of pharmacology and the development of effective therapies against neurological disease.”
Viewing his contributions in the field of pharmacology, his research was further supported by funding from the National Institute on Aging and the Michael J. Fox Foundation for Parkinson’s Research. This funding supports projects that work to extend the quality and health of aging individuals nationwide and promote improvements in the lives of people with Parkinson’s Disease. Therefore, his research has major implications for curing neurodegenerative diseases, which primarily affect older populations.
All of these aforementioned facts, when put together, led our client to the O1A approval. We are delighted that we got the opportunity to help him in this process and achieved his O-1A petition approval in just 7 days. Also, we would like to give a special thanks to the premium processing upgrade, a paid option offered by the USCIS that allows petitioners to enjoy expedited adjudication (the case will be processed within 15 days instead of 9-12 months). We congratulate and wish our client all the best in his future endeavors.